IMMUNOMEDICS, INC.

AFP-SCAN

reagents used to prepare radiolabeled medical diagnostic radioimmunodetection agents used in the detection of cancer in patients;

CEA-CIDE

therapeutic agent for antibody-targeted treatment of colorectal cancer and other cancers associated with CEA antigen;SEA SIDE;

CEA-SCAN

radioimmunodetection reagents used in the detection of cancer in patients;

CLIVATUCYN

pharmaceutical preparations for the treatment of cancer, particularly monoclonal antibodies for treatment of pancreatic cancer;

D-TEC-IV-CEA

radioactive antibodies for diagnosing the distribution of cancer in the body;

EPRACYN

Pharmaceutical preparations for treatment of cancer;

EPRATUCYN

Pharmaceutical preparation, namely, therapeutic agents for parenteral use for the treatment of cancer;

EUROMEDICS

EURO - MEDICS;immunodiagnostic kits comprising immunological reagents;

EUROMEDICS

kits containing a monoclonal antibody to be combined with various imaging and therapeutic compounds for use in the in-vivo diagnosis and treatment of cancer, infectious diseases, and inflammatory diseases;The lining shown in the mark is a feature of the mark and is not intended to indicate color.;

FIBROSCAN

diagnostic kit comprising diagnostic reagents in the nature of antibodies or antibody fragments and radiolabeling accessories for in vivo radioantibody detection of fibrosis;FIBRO-SCAN;

FIBROSCAN

diagnostic kit comprising diagnostic reagents in the nature of antibodies or antibody fragments and radiolabeling accessories for in vivo radioantibody detection of fibrosis;FIBROSIS SCAN;

GRANULOSITE

diagnostic reagents in the nature of antibodies or antibody fragments and radiolabeling accessories; namely, vials and syringes containing such reagents, for in vivo radioantibody detection of infectious lesions;

HUMANLY

Educational services, namely, providing ongoing information to patients and healthcare providers regarding cancer care, cancer treatments, cancer diagnosis via workshops, conferences and online training;Providing a website featuring information about health and wellness services relating to oncology topics; providing health related information in the form of recommended educational resources and treatment information;

IMMUNOMEDICS

IMMUNODIAGNOSTIC KITS COMPRISING PRIMARILY IMMUNOLOGICAL REAGENTS;

IMMUNOMEDICS

IMMUNODIAGNOSTIC KITS COMPRISING PRIMARILY IMMUNOLOGICAL REAGENTS;THE LINING IN THE DRAWING DOES NOT DEPICT COLOR.;

IMMUNOMEDICS

immunodiagnostic kits comprising primarily immunological reagents;

IMMUNOMEDICS

immunodiagnostic kits comprising primarily immunological reagents;The lining in the drawing is a feature of the mark and is not intended to indicate color.;

IMMUNOMEDICS

Therapeutic pharmaceuticals, namely, antibodies and immunoconjugates for the treatment of cancer and autoimmune diseases;IMMUNE MEDICS;

IMMUNOMEDICS

The mark consists of the trademark IMMUNOMEDICS with a six sided geometric design to its left.;Therapeutic pharmaceuticals, namely, antibody-drug conjugates for the treatment of cancer;Color is not claimed as a feature of the mark.;

IMMUNOVAX

Reagents in the nature of antibodies and antibody fragments for use as vaccines to treat tumors and infectious lesions;

IMMUPROBE

diagnostic kits for the detection of tumors, infectious lesions, and other disease manifestations, comprising reagents, antibodies, antibody fragments and radiolabeling accessories in the nature of vials, syringes, pipettes, and radiolabeling reagents;IMMU-PROBE;

IMMUPROBE

diagnostic kits for the detection of tumors, infectious lesions, and other disease manifestations, comprising reagents, antibodies, antibody fragments and radiolabeling accessories in the nature of vials, syringes, pipettes, and radiolabeling reagents;

IMMURAID

radioactively labeled antibodies used to diagnose cancer and other tumerous diseases;

IMMUSCAN

diagnostic kit comprising diagnostic reagents in the nature of antibodies or antibody fragments and radiolabeling accessories for in vivo radioantibody detection of infectious lesions;

IMMUSCAN

diagnostic reagents in the nature of antibodies or antibody fragments and radiolabeling accessories for in vivo radioantibody detection of tumors and infectious lesions;IMMUNOMEDICS SCAN;

IMMUSTRIP

IMMUNOSTRIP;IMMUNOASSAY KITS FOR IN VITRO MEDICAL AND LABORATORY DIAGNOSTIC USE;

IMMUSTRIP

IMMUNOMEDICS STRIP;immunoassay kits for in vitro medical and laboratory diagnostic use;

IMMUVAX

reagents in the nature of antibodies or antibody fragments for use as vaccines to treat tumors and infectious lesions;

LEUKOSCAN

diagnostic kit comprising diagnostic reagents in the nature of antibodies or antibody fragments and radiolabeling accessories for in vivo radioantibody detection of infectious lesions;

LEUKOSITE

diagnostic regents in the nature of antibodies or antibody fragments and radiolabeling accessories for in vivo radioantibody detection of infectious lesions;

LYMPHOCIDE

therapeutic agent for antibody-targeted treatment of lymphoma;

LYMPHOSCAN

radioimmunodetection reagents used in the detection of cancer;

LYMPHOTECT

diagnostic kit comprising diagnostic reagents in the nature of antibodies or antibody fragments and radiolabeling accessories for in vivo radioantibody detection of lymphomas;

MILATUCYN

pharmaceutical preparations for the treatment of cancer, particularly monoclonal antibodies for treatment of hematological tumors and solid cancers, and pharmaceutical preparations for the treatment of inflammatory diseases, including autoimmune diseases, immune dysregulation and transplant-related diseases, particularly monoclonal antibodies for treatment of these diseases;

MYELOCIDE

Antibody-targeted therapeutic agent for treatment of multiple myeloma;

MYELOSCAN

bone marrow imaging agent for clinical or medical laboratory use;

PANCRIT

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields;

PCP-SCAN

radioimmunodetection reagents used in the detection of infection in patients;

RAID

radioactively-labeled antibodies used to diagnose cancer and other tumorous diseases;

RAIT

radioactively-labeled anti-bodies used to treat cancer and other tumorous diseases;

SCIGOVI

pharmaceutical preparations for the treatment of oncological disorders, hematological disorders and auto-immune disorders;The word(s) SCIGOVI has no meaning in a foreign language.;

TRODELVY

In the statement, line 5, hematological disorders and auto-immune disorders is deleted.;pharmaceutical preparations for the treatment of oncological disorders [, hematological disorders and auto-immune disorders ];The word(s) TRODELVY has no meaning in a foreign language.;

TRODELVY

The mark consists of Four ovals overlapping at its base to the left of the word TRODELVY.;Pharmaceutical preparations for the treatment of oncological disorders, autoimmune disorders, inflammatory disorders and hematological disorders;Color is not claimed as a feature of the mark.;